Basic Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Nov 21, 2008; 14(43): 6673-6680
Published online Nov 21, 2008. doi: 10.3748/wjg.14.6673
Figure 4
Figure 4 RT-PCR and Western blot analysis of differentiated WB-F344 cells treated or untreated with Wnt3a. A: Wnt3a-treated WB-F344 cells expressing two phenotypic markers (CK-19 and AFP) and two hepatic nuclear factors (HNF4α and HNF-6) at mRNA level with untreated WB-F344 cells as controls; B: Wnt3a-treated cells expressing two phenotypic markers (CK-19 and AFP) at protein level.